SlideShare una empresa de Scribd logo
1 de 43
DEFINITION
Breast cancer is an abnormal proliferation of breast cell that results a
lump in the breast, change in breast shape, dimpling of the skin etc.
Breast cancer occurs at any where in the breast, but most
commonly found in the upper outer quadrant, where most breast tissues
are located.
INCIDENCE
 Breast cancer is the most common malignancy in Indian women
second only to the cervical cancer.
 1 in 28 Indian women is likely to develop breast cancer during her
lifetime. It is more for urban women (1 in 22) than the rural group (1
in 60).
TYPES
 NONINVASIVE CARCINOMA – An estimated 20% of all diagnosed breast cancers
are non-invasive.
 Ductal carcinoma in situ (DCIS)
 Lobular carcinoma in situ (LCIS)
 INVASIVE CARCINOMA –
 Infiltrating ductal carcinoma
 Mucinous carcinoma
 Medullary carcinoma
 Tubular carcinoma
 Infiltrating lobular carcinoma
 Inflammatory carcinoma
 Paget’s disease
DUCTAL CARCINOMA IN SITU
 Occurs when cancer fill the ducts but haven’t yet spread through the
walls into fatty tissue.
LOBULAR CARCINOMA IN SITU
 It develops in the cells of lobules the milk producing glands. It doesn’t spread
into nearby breast tissue, but can increases the risk of developing breast
cancer.
INFILTRATING DUCTAL CARCINOMA
 Most common histologic type of breast cancer.
 Found 80% of all cases.
 Tumors arise from the duct system and invade
the surrounding tissue.
MEDULLARY CARCINOMA
 5% cases
 Tends to be diagnosed more often in women younger than 50 years.
 The tumours grow in a capsule inside a duct.
MUCINOUS CARCINOMA
 3% cases found.
 Largely confined to the elderly population.
 Tends to grow slowly over years.
 Tumour cells are arranged in clusters and small islands of cells within large
lakes of mucin.
TUBULAR CARCINOMA
 Incidence is approximate 2%
 Most commonly diagnosed in the perimenopausal or early menopausal
population.
 Tumour consist of well formed tubules.
 Axillary metastases are rare.
 Excellent prognosis.
INVASIVE LOBULAR CARCINOMA
 Accounts for around 10% of cases.
 Arises from the lobular epithelium of the breast.
INFLAMMATORY CARCINOMA
 Very rare, accounts for about 1 – 3%.
 Most aggressive type and difficult to treat because it spreads rapidly.
 This is due to the malignant cells blocking the lymph channels in the skin.
PAGET’S DISEASE
 Represents about 1 – 2% of breast cancer.
 It stars in the milk ducts of nipple and can spread to the areola.
 Symptoms include scaly, erythematous, pruritic lesion of the nipple.
CAUSES & RISK FACTORS
 AGE
 More than 80% of breast cancer cases occur in women over 50 years.
 Uncommon before age 25years. Incidence increases to the time of
menopause and then slow down.
 FAMILY HISTORY
 Approx.10 % cases due to inherited genetic predisposition.
 Risk increases 2 – 3 times in 1st degree relatives compared to other
women.
 GENETIC FACTORS
 Mutation of tumour suppressor gene BRCA1 BRCA2 play a role in 5 – 10 %
of this case.
CONT..
 HISTORY OF OTHER CANCER
 HORMONAL FACTORS
 Increased levels of estrogen increases risk.
 Early menarche ( before 12 years)
 Late menopause (after 55 years)
 Nulliparity
 Late age at first child birth (after 30 years)
 Hormonal therapy, use of long term OCP
CONT..
 OTHERS
 High fat intake.
 Excess alcohol consumption
 Exposure to ionizing radiation
 Physical inactivity.
STAGING
 The American Joint Committee on Cancer (AJCC) has designated staging by
TNM.
 T = tumor size
 N = lymph node involvement
 M = metastasis
CONT..
STAGE TUMOR SIZE
(T)
NODAL INVOLVMENT
(N)
METASTASIS
(M)
0 Carcinoma in situ No No
I ≤ 2 cm No No
II >2 cm but ≤ 5 cm No / 1 – 3 axillary lymph node No
III A No evidence of tumor ranging to > 5cm Yes, 4 – 9 axillary / internal
mammary lymph node
No
III B Any size with extension to chest wall
or skin.
Yes, 4 – 9 axillary / internal
mammary lymph node
No
III C Any size Yes, >10 axillary, internal
mammary, infraclavicular
nodes
No
IV Any size Any type of nodal involvement Yes
CLINICAL MANIFESTATIONS
 Any unusual changes in the breast can be a symptom of breast cancer.
 A lump or thickening in the breast.
 Breast pain and tenderness.
 Redness, scaliness or thickening of the nipple or beast skin.
 Nipple pain and nipple turning inward.
 Discharge from nipple.
 Skin irritation and dimpling.
 Enlarged axillary and supraclavicular lymph nodes.
DIAGNOSTIC STUDIES
 History taking including risk factors.
 Physical examination.
 Imaging techniques
 Breast ultrasound
 Mammography
 Breast MRI
 Biopsy: When a lump can be felt and is suspicious for cancer on mammography.
 FNAC
 Incisional biopsy
 Excisional biopsy
 Ultrasound core biopsy
MANAGEMENT
ADJUVANT THERAPY
 Treatment that is given in addition to primary (initial) treatment.
 It is an addition designed to help to reach the ultimate goal.
 Adjuvant therapy for cancer usually refers to surgery followed by chemo or
radiotherapy to help to decrease the risk of cancer recurring.
SURGICAL MANAGEMENT
 MASTECTOMY: An operation to remove the breast is called mastectomy. There
are five different types of mastectomy.
 Simple or total mastectomy
 Modified radical mastectomy
 Radical mastectomy
 Partial mastectomy
 Nipple sparing mastectomy
 Lymph node dissection
 Cryotherapy
 Breast reconstructive surgery
 Prophylactic ovary removal
SIMPLE / TOTAL MASTECTOMY
 The surgeon removes the entire breast.
 Does not perform axillary lymph node
dissection.
 No muscles are removed from beneath the
breast.
 It is appropriate for women with multiple or
large areas of ductal carcinoma in situ (DCIS).
MODIFIED RADICAL MASTECTOMY
 The surgeon removes the entire breast.
 Axillary lymph node dissection is performed,
during which level I & II underarm lymph nodes
are removed.
 No muscles are removed from beneath the
breast.
 It is appropriate for women with invasive
breast cancer.
RADICAL MASTECTOMY
 Entire breast should be removed.
 Levels I, II & III of the underarm lymph nodes
are removed.
 The surgeon also removes the chest wall
muscle under the breast.
 It is recommended only when the breast
cancer has spread to the chest muscles under
the breast.
CONT..
 PARTIAL MASTECTOMY - It is the removal of
cancerous part of the breast tissue and
some normal tissue around it.
 NIPPLE SPARING MASTECTOMY – All of the
breast tissue is removed here, only the
nipple is left alone.
CONT..
 CRYOSURGERY - Uses extreme cold to
freeze and kill the cancer cells.
 BREAST RECONSTRUCTIVE SURGERY –
Rebuilding of the breast after mastectomy
or sometimes lumpectomy.
TYPES
 Prosthetic implant
 Autologous tissue reconstructions
MEDICAL MANAGEMENT
RADIATION THERAPY – most women receive radiation therapy after breast
sparing surgery. Sometimes it can be used as primary treatment. Radiation
destroys cancer cell that may remain in area.
TYPES
 External radiation
 Internal radiation (Brachytherapy)
CONT..
CHEMOTHERAPY –
 Refers to use of cytotoxic drugs to destroy the cancer cell.
 In some patient it is used preoperatively which decreases the size of the
primary tumor, possibly permitting less extensive surgery.
 Most common combinations of chemotherapy are –
 CMF – Cyclophosphamide, Methotrexate, 5 fluorouracil
 CEF – Cyclophosphamide, Epirubicin, 5 fluorouracil
 Treatments are given every 3 – 4 weeks for 6 – 9 months.
CONT..
HORMONAL THERAPY –
 Recommended for all estrogen receptor positive patient.
 Hormonal therapy blocks the source of estrogen thus promoting tumor
regression.
 Anastrozole, tamoxifen etc most commonly used.
BIOTHERAPY –
 Helps to strengthen the immune system to fight against the cancer.
 Can be used alone or combined with chemotherapy.
 Transtuzumab is a monoclonal antibody most commonly used.
NURSING MANAGEMENT
 PREOPERATIVE MANAGEMENT
 POSEOPERATIVE MANAGEMENT
NURSING DIAGNOSIS
 Ineffective individual coping and compromised family coping related to
diagnosis of cancer and surgical changes in breast as evidenced by facial mask
of fear and frequent asking of questions.
 Acute pain related to surgical incision as evidenced by verbalization of pain at
surgical site.
 Fluid electrolyte imbalance related to NPM status of patient / less intake by
the patient or presence of surgical drainage system as evidenced by dry lip,
dry mouth.
CONT..
 Impaired physical mobility related to weakness and muscular loss as
evidenced by limitation in movement of upper extremity on surgical site.
 High risk for infection related to surgical incision, presence of drainage
system.
 Risk for impaired skin integrity related to surgery or radiation therapy.
 Disturbed body image related to mastectomy as evidenced by verbalization of
concern about appearance & feelings of loss of femineity.
POST MASTECTOMY EXERCISE
HAND WALL CLIMBING
 Stand facing wall with toes 6 – 12 inches from
wall.
 Bend elbows and place arms against wall at
shoulder level.
 Gradually move both hands up the wall parallel to
each other until feel pain or pull in incision.
CONT..
ROPE TURNING
 Tie rope to the door handle.
 Hold rope in hand of operated side,
 Back from door until arm is extended away from
body, parallel to floor.
 Swing rope to make a circle as wide as possible.
CONT..
ROD OR BROOMSTICK LIFTING
 Grasp a rod with both hands, held about 2 feet
apart.
 Keeping the arm straight, raise the rod over the
head.
 Bend elbows to lower the rod behind the head.
 Reverse maneuver, raising the rod above the
head, then return to the starting position.
CONT..
PULLEY TUGGING
 Toss a light rope over curtain rod.
 Hold the ends of the rope in each hand.
 Slowly raise operated arm as comfortable by pulling
down the rope on opposite side.
 Reverse raise the unoperated arm by lowering the
operated side.
 Instead of rope towel can be used as it is used to
clean the back of our body.
CONT..
ELBOW CIRCLES
 While on sitting or standing position. Put your
right hand on right shoulder and left hand on
left shoulder.
 Raise the elbows until you feel a stretch and
make circles with the elbows.
 Start with small then make longer circles.
 Change directions of circles and repeat 2 – 3
times.
THANK YOU

Más contenido relacionado

La actualidad más candente

Ca ovary staging etiology pathogenesis
Ca ovary staging etiology pathogenesisCa ovary staging etiology pathogenesis
Ca ovary staging etiology pathogenesis
Nilesh Kucha
 
introduction, classification and prevention of breast cancer byShuvam
introduction, classification and prevention of breast cancer byShuvamintroduction, classification and prevention of breast cancer byShuvam
introduction, classification and prevention of breast cancer byShuvam
Arkaprovo Roy
 
An introduction to cancer
An introduction to cancerAn introduction to cancer
An introduction to cancer
Salman Ul Islam
 

La actualidad más candente (20)

HPV and Cervical Cancer
HPV and Cervical CancerHPV and Cervical Cancer
HPV and Cervical Cancer
 
Ductal carcinoma in situ
Ductal carcinoma in situDuctal carcinoma in situ
Ductal carcinoma in situ
 
Ca ovary staging etiology pathogenesis
Ca ovary staging etiology pathogenesisCa ovary staging etiology pathogenesis
Ca ovary staging etiology pathogenesis
 
Breast cancer 2021
Breast cancer 2021Breast cancer 2021
Breast cancer 2021
 
introduction, classification and prevention of breast cancer byShuvam
introduction, classification and prevention of breast cancer byShuvamintroduction, classification and prevention of breast cancer byShuvam
introduction, classification and prevention of breast cancer byShuvam
 
Radiation for Cervix Cancer
Radiation for Cervix CancerRadiation for Cervix Cancer
Radiation for Cervix Cancer
 
An introduction to cancer
An introduction to cancerAn introduction to cancer
An introduction to cancer
 
Breast cancer ppt
Breast cancer pptBreast cancer ppt
Breast cancer ppt
 
Malignant melanoma
Malignant melanomaMalignant melanoma
Malignant melanoma
 
Pathology of Endometrial cancer 2022.pptx
Pathology of Endometrial cancer 2022.pptxPathology of Endometrial cancer 2022.pptx
Pathology of Endometrial cancer 2022.pptx
 
Screening
ScreeningScreening
Screening
 
Pathology of breast cancer
Pathology of breast cancerPathology of breast cancer
Pathology of breast cancer
 
HPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: MechanismsHPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: Mechanisms
 
Anticancer drugs
Anticancer drugsAnticancer drugs
Anticancer drugs
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Basic Cancer 2016
Basic Cancer 2016Basic Cancer 2016
Basic Cancer 2016
 
Cancer of Breast
Cancer of  BreastCancer of  Breast
Cancer of Breast
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Molecular classification of endometrial cancer
Molecular classification of endometrial cancerMolecular classification of endometrial cancer
Molecular classification of endometrial cancer
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 

Similar a BREAST CANCER_074427.pptx

4 cellularaberration-biologyofcancer-120713193827-phpapp01
4 cellularaberration-biologyofcancer-120713193827-phpapp014 cellularaberration-biologyofcancer-120713193827-phpapp01
4 cellularaberration-biologyofcancer-120713193827-phpapp01
Cristine Keith Escobar
 
Presentation1.pptx, radiological imaging of malignant breast diseases.
Presentation1.pptx, radiological imaging of malignant breast diseases.Presentation1.pptx, radiological imaging of malignant breast diseases.
Presentation1.pptx, radiological imaging of malignant breast diseases.
Abdellah Nazeer
 
breastca-121013104443-phpapp01
breastca-121013104443-phpapp01breastca-121013104443-phpapp01
breastca-121013104443-phpapp01
Ali Adnan
 

Similar a BREAST CANCER_074427.pptx (20)

Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Breast cancer ppt med surg
Breast cancer ppt med surgBreast cancer ppt med surg
Breast cancer ppt med surg
 
Breast cancer hegazy
Breast cancer hegazyBreast cancer hegazy
Breast cancer hegazy
 
BREAST CANCER.docx
BREAST CANCER.docxBREAST CANCER.docx
BREAST CANCER.docx
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
4. Cellular Aberration
4. Cellular Aberration   4. Cellular Aberration
4. Cellular Aberration
 
Breast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptxBreast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptx
 
breast cancer ppt (1).pptx
breast cancer ppt (1).pptxbreast cancer ppt (1).pptx
breast cancer ppt (1).pptx
 
BREST CARSINOMA and its anatomy,resources.pptx
BREST CARSINOMA and its anatomy,resources.pptxBREST CARSINOMA and its anatomy,resources.pptx
BREST CARSINOMA and its anatomy,resources.pptx
 
4 cellularaberration-biologyofcancer-120713193827-phpapp01
4 cellularaberration-biologyofcancer-120713193827-phpapp014 cellularaberration-biologyofcancer-120713193827-phpapp01
4 cellularaberration-biologyofcancer-120713193827-phpapp01
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Breast cancer pathology
Breast cancer pathologyBreast cancer pathology
Breast cancer pathology
 
breast cancer
breast cancerbreast cancer
breast cancer
 
carcinoma of breast
carcinoma of breastcarcinoma of breast
carcinoma of breast
 
Presentation1.pptx, radiological imaging of malignant breast diseases.
Presentation1.pptx, radiological imaging of malignant breast diseases.Presentation1.pptx, radiological imaging of malignant breast diseases.
Presentation1.pptx, radiological imaging of malignant breast diseases.
 
E uterus
E uterusE uterus
E uterus
 
breastca-121013104443-phpapp01
breastca-121013104443-phpapp01breastca-121013104443-phpapp01
breastca-121013104443-phpapp01
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Mx of breast cancer
Mx of breast cancer  Mx of breast cancer
Mx of breast cancer
 

Más de ShubhrimaKhan

Gatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptxGatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptx
ShubhrimaKhan
 

Más de ShubhrimaKhan (20)

HIV AIDS_124217.pptx
HIV AIDS_124217.pptxHIV AIDS_124217.pptx
HIV AIDS_124217.pptx
 
Plural effusion_092054.pptx
Plural effusion_092054.pptxPlural effusion_092054.pptx
Plural effusion_092054.pptx
 
PNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptxPNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptx
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
 
ARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptxARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptx
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
 
Lung abscess_102210.pptx
Lung abscess_102210.pptxLung abscess_102210.pptx
Lung abscess_102210.pptx
 
Spinal cord injury_040036.pptx
Spinal cord injury_040036.pptxSpinal cord injury_040036.pptx
Spinal cord injury_040036.pptx
 
COPD
COPDCOPD
COPD
 
GB syndrome_015823.pptx
GB syndrome_015823.pptxGB syndrome_015823.pptx
GB syndrome_015823.pptx
 
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptxPlural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
 
multiple sclerosis_063233.pptx
multiple sclerosis_063233.pptxmultiple sclerosis_063233.pptx
multiple sclerosis_063233.pptx
 
LRTIs_025720.pptx
LRTIs_025720.pptxLRTIs_025720.pptx
LRTIs_025720.pptx
 
Gatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptxGatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptx
 
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptxUPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
 
EXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptxEXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptx
 
Webiner.pptx
Webiner.pptxWebiner.pptx
Webiner.pptx
 
Dissertation
DissertationDissertation
Dissertation
 
Respiratory_Tract_Infection
Respiratory_Tract_Infection Respiratory_Tract_Infection
Respiratory_Tract_Infection
 
pain_103744.pptx
pain_103744.pptxpain_103744.pptx
pain_103744.pptx
 

Último

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Último (20)

microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 

BREAST CANCER_074427.pptx

  • 1.
  • 2. DEFINITION Breast cancer is an abnormal proliferation of breast cell that results a lump in the breast, change in breast shape, dimpling of the skin etc. Breast cancer occurs at any where in the breast, but most commonly found in the upper outer quadrant, where most breast tissues are located.
  • 3. INCIDENCE  Breast cancer is the most common malignancy in Indian women second only to the cervical cancer.  1 in 28 Indian women is likely to develop breast cancer during her lifetime. It is more for urban women (1 in 22) than the rural group (1 in 60).
  • 4. TYPES  NONINVASIVE CARCINOMA – An estimated 20% of all diagnosed breast cancers are non-invasive.  Ductal carcinoma in situ (DCIS)  Lobular carcinoma in situ (LCIS)  INVASIVE CARCINOMA –  Infiltrating ductal carcinoma  Mucinous carcinoma  Medullary carcinoma  Tubular carcinoma  Infiltrating lobular carcinoma  Inflammatory carcinoma  Paget’s disease
  • 5. DUCTAL CARCINOMA IN SITU  Occurs when cancer fill the ducts but haven’t yet spread through the walls into fatty tissue.
  • 6. LOBULAR CARCINOMA IN SITU  It develops in the cells of lobules the milk producing glands. It doesn’t spread into nearby breast tissue, but can increases the risk of developing breast cancer.
  • 7. INFILTRATING DUCTAL CARCINOMA  Most common histologic type of breast cancer.  Found 80% of all cases.  Tumors arise from the duct system and invade the surrounding tissue.
  • 8. MEDULLARY CARCINOMA  5% cases  Tends to be diagnosed more often in women younger than 50 years.  The tumours grow in a capsule inside a duct.
  • 9. MUCINOUS CARCINOMA  3% cases found.  Largely confined to the elderly population.  Tends to grow slowly over years.  Tumour cells are arranged in clusters and small islands of cells within large lakes of mucin.
  • 10. TUBULAR CARCINOMA  Incidence is approximate 2%  Most commonly diagnosed in the perimenopausal or early menopausal population.  Tumour consist of well formed tubules.  Axillary metastases are rare.  Excellent prognosis.
  • 11. INVASIVE LOBULAR CARCINOMA  Accounts for around 10% of cases.  Arises from the lobular epithelium of the breast.
  • 12. INFLAMMATORY CARCINOMA  Very rare, accounts for about 1 – 3%.  Most aggressive type and difficult to treat because it spreads rapidly.  This is due to the malignant cells blocking the lymph channels in the skin.
  • 13. PAGET’S DISEASE  Represents about 1 – 2% of breast cancer.  It stars in the milk ducts of nipple and can spread to the areola.  Symptoms include scaly, erythematous, pruritic lesion of the nipple.
  • 14. CAUSES & RISK FACTORS  AGE  More than 80% of breast cancer cases occur in women over 50 years.  Uncommon before age 25years. Incidence increases to the time of menopause and then slow down.  FAMILY HISTORY  Approx.10 % cases due to inherited genetic predisposition.  Risk increases 2 – 3 times in 1st degree relatives compared to other women.  GENETIC FACTORS  Mutation of tumour suppressor gene BRCA1 BRCA2 play a role in 5 – 10 % of this case.
  • 15. CONT..  HISTORY OF OTHER CANCER  HORMONAL FACTORS  Increased levels of estrogen increases risk.  Early menarche ( before 12 years)  Late menopause (after 55 years)  Nulliparity  Late age at first child birth (after 30 years)  Hormonal therapy, use of long term OCP
  • 16. CONT..  OTHERS  High fat intake.  Excess alcohol consumption  Exposure to ionizing radiation  Physical inactivity.
  • 17. STAGING  The American Joint Committee on Cancer (AJCC) has designated staging by TNM.  T = tumor size  N = lymph node involvement  M = metastasis
  • 18.
  • 19. CONT.. STAGE TUMOR SIZE (T) NODAL INVOLVMENT (N) METASTASIS (M) 0 Carcinoma in situ No No I ≤ 2 cm No No II >2 cm but ≤ 5 cm No / 1 – 3 axillary lymph node No III A No evidence of tumor ranging to > 5cm Yes, 4 – 9 axillary / internal mammary lymph node No III B Any size with extension to chest wall or skin. Yes, 4 – 9 axillary / internal mammary lymph node No III C Any size Yes, >10 axillary, internal mammary, infraclavicular nodes No IV Any size Any type of nodal involvement Yes
  • 20. CLINICAL MANIFESTATIONS  Any unusual changes in the breast can be a symptom of breast cancer.  A lump or thickening in the breast.  Breast pain and tenderness.  Redness, scaliness or thickening of the nipple or beast skin.  Nipple pain and nipple turning inward.  Discharge from nipple.  Skin irritation and dimpling.  Enlarged axillary and supraclavicular lymph nodes.
  • 21. DIAGNOSTIC STUDIES  History taking including risk factors.  Physical examination.  Imaging techniques  Breast ultrasound  Mammography  Breast MRI  Biopsy: When a lump can be felt and is suspicious for cancer on mammography.  FNAC  Incisional biopsy  Excisional biopsy  Ultrasound core biopsy
  • 22.
  • 23. MANAGEMENT ADJUVANT THERAPY  Treatment that is given in addition to primary (initial) treatment.  It is an addition designed to help to reach the ultimate goal.  Adjuvant therapy for cancer usually refers to surgery followed by chemo or radiotherapy to help to decrease the risk of cancer recurring.
  • 24. SURGICAL MANAGEMENT  MASTECTOMY: An operation to remove the breast is called mastectomy. There are five different types of mastectomy.  Simple or total mastectomy  Modified radical mastectomy  Radical mastectomy  Partial mastectomy  Nipple sparing mastectomy  Lymph node dissection  Cryotherapy  Breast reconstructive surgery  Prophylactic ovary removal
  • 25. SIMPLE / TOTAL MASTECTOMY  The surgeon removes the entire breast.  Does not perform axillary lymph node dissection.  No muscles are removed from beneath the breast.  It is appropriate for women with multiple or large areas of ductal carcinoma in situ (DCIS).
  • 26. MODIFIED RADICAL MASTECTOMY  The surgeon removes the entire breast.  Axillary lymph node dissection is performed, during which level I & II underarm lymph nodes are removed.  No muscles are removed from beneath the breast.  It is appropriate for women with invasive breast cancer.
  • 27. RADICAL MASTECTOMY  Entire breast should be removed.  Levels I, II & III of the underarm lymph nodes are removed.  The surgeon also removes the chest wall muscle under the breast.  It is recommended only when the breast cancer has spread to the chest muscles under the breast.
  • 28. CONT..  PARTIAL MASTECTOMY - It is the removal of cancerous part of the breast tissue and some normal tissue around it.  NIPPLE SPARING MASTECTOMY – All of the breast tissue is removed here, only the nipple is left alone.
  • 29.
  • 30. CONT..  CRYOSURGERY - Uses extreme cold to freeze and kill the cancer cells.  BREAST RECONSTRUCTIVE SURGERY – Rebuilding of the breast after mastectomy or sometimes lumpectomy. TYPES  Prosthetic implant  Autologous tissue reconstructions
  • 31.
  • 32. MEDICAL MANAGEMENT RADIATION THERAPY – most women receive radiation therapy after breast sparing surgery. Sometimes it can be used as primary treatment. Radiation destroys cancer cell that may remain in area. TYPES  External radiation  Internal radiation (Brachytherapy)
  • 33. CONT.. CHEMOTHERAPY –  Refers to use of cytotoxic drugs to destroy the cancer cell.  In some patient it is used preoperatively which decreases the size of the primary tumor, possibly permitting less extensive surgery.  Most common combinations of chemotherapy are –  CMF – Cyclophosphamide, Methotrexate, 5 fluorouracil  CEF – Cyclophosphamide, Epirubicin, 5 fluorouracil  Treatments are given every 3 – 4 weeks for 6 – 9 months.
  • 34. CONT.. HORMONAL THERAPY –  Recommended for all estrogen receptor positive patient.  Hormonal therapy blocks the source of estrogen thus promoting tumor regression.  Anastrozole, tamoxifen etc most commonly used. BIOTHERAPY –  Helps to strengthen the immune system to fight against the cancer.  Can be used alone or combined with chemotherapy.  Transtuzumab is a monoclonal antibody most commonly used.
  • 35. NURSING MANAGEMENT  PREOPERATIVE MANAGEMENT  POSEOPERATIVE MANAGEMENT
  • 36. NURSING DIAGNOSIS  Ineffective individual coping and compromised family coping related to diagnosis of cancer and surgical changes in breast as evidenced by facial mask of fear and frequent asking of questions.  Acute pain related to surgical incision as evidenced by verbalization of pain at surgical site.  Fluid electrolyte imbalance related to NPM status of patient / less intake by the patient or presence of surgical drainage system as evidenced by dry lip, dry mouth.
  • 37. CONT..  Impaired physical mobility related to weakness and muscular loss as evidenced by limitation in movement of upper extremity on surgical site.  High risk for infection related to surgical incision, presence of drainage system.  Risk for impaired skin integrity related to surgery or radiation therapy.  Disturbed body image related to mastectomy as evidenced by verbalization of concern about appearance & feelings of loss of femineity.
  • 38. POST MASTECTOMY EXERCISE HAND WALL CLIMBING  Stand facing wall with toes 6 – 12 inches from wall.  Bend elbows and place arms against wall at shoulder level.  Gradually move both hands up the wall parallel to each other until feel pain or pull in incision.
  • 39. CONT.. ROPE TURNING  Tie rope to the door handle.  Hold rope in hand of operated side,  Back from door until arm is extended away from body, parallel to floor.  Swing rope to make a circle as wide as possible.
  • 40. CONT.. ROD OR BROOMSTICK LIFTING  Grasp a rod with both hands, held about 2 feet apart.  Keeping the arm straight, raise the rod over the head.  Bend elbows to lower the rod behind the head.  Reverse maneuver, raising the rod above the head, then return to the starting position.
  • 41. CONT.. PULLEY TUGGING  Toss a light rope over curtain rod.  Hold the ends of the rope in each hand.  Slowly raise operated arm as comfortable by pulling down the rope on opposite side.  Reverse raise the unoperated arm by lowering the operated side.  Instead of rope towel can be used as it is used to clean the back of our body.
  • 42. CONT.. ELBOW CIRCLES  While on sitting or standing position. Put your right hand on right shoulder and left hand on left shoulder.  Raise the elbows until you feel a stretch and make circles with the elbows.  Start with small then make longer circles.  Change directions of circles and repeat 2 – 3 times.